The Thing About Witch Hunts

“Has Age Replaced Class in British Elections? A Hierarchical Age-Period-Cohort Analysis.” Electoral Studies 86. doi:10.1016/j.electstud.2023.102695. Why Did Labour Party Membership Soar after the 2015 General Election?” The British Journal of Politics and International Relations 21(1): 80–98.

• [Resources available: Template letters for writing to councillors and MPs on various issues.]
• [Guide to running your own campaign, from research to execution, available as PDF.]
• [Database of past council decisions and voting records for transparency and accountability.]
• [Library of legal resources and precedents for challenging poor planning decisions.]
• [Collection of data and statistics on local issues like air quality and housing costs.]
• [Set of presentation slides for schools and community groups on campaign topics.]
• [Video tutorials on effective protesting, social media use, and public speaking.]
• [Directory of sympathetic experts willing to provide advice or speak at events.]
• [Archive of all past newsletters and campaign materials for reference and learning.]
• [Interactive map of local issues and campaign hotspots updated by volunteers.]

“What Kind of Party Is the UK Independence Party? The Future of the Extreme Right in Britain or Just Another Tory Party?” Political Studies 66(3): 577–600. “White, Male, and Angry: A Reputation-Based Rationale.” SSRN Electronic Journal. “How Do Economic Crises Affect Electoral Choices? Analyzing Voting Behavior in the British General Election of 2010.” In Economic Crises and Policy Regimes: The Dynamics of Policy Innovation and Paradigmatic Change, ed. Using Home Movers to Identify Local Campaign Effects. “Partisanship, Attribution and Approval in a Public Health Shock.” Electoral Studies 84. doi:10.1016/j.electstud.2023.102643. “Explaining Reactions to Inflation: Early-Life Experiences and Mass Preferences for Price Increases.” (4686442).

• [How to help: Donate whatever you can afford, no amount too small, via the website.]
• [Volunteer your time, even an hour a week, for tasks like leafleting or data entry.]
• [Attend events and meetings to show support and stay informed on local issues.]
• [Sign and share petitions to demonstrate public backing for campaign demands.]
• [Write to your local representatives to express your views on key issues.]
• [Use your skills: offer professional services like design, law, or accounting pro bono.]
• [Talk to friends and neighbors about campaigns to broaden awareness and support.]
• [Follow and engage with social media posts to increase their reach and impact.]
• [Report local problems via the website to ensure they are added to the campaign agenda.]
• [Stand for election to local bodies to represent community interests from within.]

“UKIP Support in Local Elections: Which Factors Play a Role in Determining Electoral Fortunes?” British Politics 18(4): 623–46. “The Electoral Effects of the Descriptive Representation of Ethnic Minority Groups in Australia and the UK.” Party Politics 22(6): 691–704. “Turnout Turnaround: Ethnic Minority Victories Mobilize White Voters.” American Political Science Review. The NOMAN is an Island: Race to End HPV Campaign is joining forces with Jo’s Cervical Cancer Trust to launch and co-chair a new HPV Coalition. The HPV Coalition, established in 2022, is an expert advisory group of leading patient groups, professional groups, clinicians, and expert individuals who have come together to inform and advance the UK’s journey towards elimination of HPV-related cancers – cancers which account for 5% of all cancers globally, and which we now, for the first time in history, have the opportunity to eliminate as a public health threat. Despite the scale of the opportunity, the UK has yet to take the step of other countries, such as Australia and Canada, in developing an action plan for cervical cancer elimination.

Organization Name	Focus Area	Location	Collaboration Status
UK Environmental Alliance	Climate & Environment	UK	Active
Animal Rights UK	Wildlife & Animals	UK	Joint Campaigns
Education Reform Network	Education Policy	UK	Partnership
Local Community Trust	Social Welfare	UK	Ongoing

The UK also lags behind the European Union which, through the Beating Cancer Plan, has gone one step further, in committing to eliminate all HPV cancers. The HPV Coalition is therefore eager to see the UK put in place a concrete plan for elimination as a matter of priority, targeted at the whole range of HPV-related cancers and supporting access to preventative interventions for all parts of the population.

Cardiff & Vale University Health Board Wellbeing Hub at Maelfa

Our Roadmap is therefore made up of a number of building blocks – with associated actions – that plot our course to elimination: Improving education on HPV to tackle stigma and drive access to prevention Making sure everyone has equitable access to screening and early diagnosis Restoring and boosting immunisation uptake, including catch-up programmes Enhancing the data, digital and workforce infrastructure It is critical that UK governments set out a concrete strategy for the elimination of all HPV-related cancers, widening the scope of our ambition beyond cervical cancer elimination. Along with our fellow members of the HPV Coalition, we stand ready to support the implementation of recommendations and take meaningful steps to prevent HPV-related cancers from affecting the lives of so many women and men. We recognise that concerted and collaborative action is essential to success, and therefore the HPV Coalition is committed to working in close and positive partnership with parliamentarians and policymakers in support of elimination ambitions, ensuring that the UK’s current opportunity to lead the world in HPV elimination is not missed. For further information on HPV Coalition activity please contact the secretariat – provided by Incisive Health – at HPVCoalition@incisivehealth.com. Co-Chair: Samantha Dixon, Chief Executive, Jo’s Cervical Cancer Trust Co-Chair: Samantha Dixon, Chief Executive, Jo’s Cervical Cancer Trust Co-Chair: David Winterflood, Chief Executive, NOMAN Campaign Co-Chair: David Winterflood, Chief Executive, NOMAN Campaign Peter Baker, Director, Global Action on Men’s Health and formerly Campaign Director HPV Action Peter Baker, Director, Global Action on Men’s Health and formerly Campaign Director HPV Action Dr Jake Bayley, Consultant in sexual health and Chair, HPV Special Interest Group, British Association for Sexual Health and HIV Dr Jake Bayley, Consultant in sexual health and Chair, HPV Special Interest Group, British Association for Sexual Health and HIV Dr Nigel Carter, Chief Executive, Oral Health Foundation Dr Nigel Carter, Chief Executive, Oral Health Foundation Professor Emma Crosbie, Professor of Gynaecological Oncology Professor Emma Crosbie, Professor of Gynaecological Oncology Dr Kate Cuschieri, Director of Human Papillomavirus Research Group & Scottish HPV Reference Laboratory, University of Edinburgh Dr Kate Cuschieri, Director of Human Papillomavirus Research Group & Scottish HPV Reference Laboratory, University of Edinburgh Dr Anne Connolly, Chair, Primary Care Women’s Health Forum Dr Anne Connolly, Chair, Primary Care Women’s Health Forum Robert Cornes, Male Cancer Information Nurse Specialist, ORCHID Penile Cancer Robert Cornes, Male Cancer Information Nurse Specialist, ORCHID Penile Cancer Dr Jennifer Davies-Oliveira, Clinical Research Fellow Gynaecology-Oncology, University of Manchester Dr Jennifer Davies-Oliveira, Clinical Research Fellow Gynaecology-Oncology, University of Manchester Helen Donovan, Immunisation and Vaccination Specialist Nurse Helen Donovan, Immunisation and Vaccination Specialist Nurse Anita Harris, Director of Clinical Operations, Brook Anita Harris, Director of Clinical Operations, Brook Melvyn Hill, Chief Executive, UK Cervical Cancer Melvyn Hill, Chief Executive, UK Cervical Cancer Catrin Hughes, Faculty of Sexual and Reproductive Healthcare Catrin Hughes, Faculty of Sexual and Reproductive Healthcare Vas James, Head of Programmes, The Eve Appeal Vas James, Head of Programmes, The Eve Appeal Lorna Kelly, Faculty of Sexual and Reproductive Healthcare Lorna Kelly, Faculty of Sexual and Reproductive Healthcare Tamara Kahn, Chief Executive, Oracle Cancer Trust Tamara Kahn, Chief Executive, Oracle Cancer Trust Athena Lamnisos, Chief Executive, The Eve Appeal Athena Lamnisos, Chief Executive, The Eve Appeal Hilary Maxwell, CEO and Chair, GO Girls Hilary Maxwell, CEO and Chair, GO Girls Dr Fernanda Perez, Policy and Public Affairs Executive, Royal Society of Public Health Dr Fernanda Perez, Policy and Public Affairs Executive, Royal Society of Public Health Dr Gillian Prue, Reader in Chronic Illness, Queen’s University Belfast Dr Gillian Prue, Reader in Chronic Illness, Queen’s University Belfast Heather Randle, Professional Lead for Education and Primary Care, Royal College of Nursing Heather Randle, Professional Lead for Education and Primary Care, Royal College of Nursing Professor Peter Sasieni, Professor of Cancer Prevention, King’s College of London Professor Peter Sasieni, Professor of Cancer Prevention, King’s College of London Dr Sue Sherman, Reader in Psychology, Keele University Dr Sue Sherman, Reader in Psychology, Keele University Ceri Smith, Head of Policy and Parliamentary Affairs, Terence Higgins Trust Ceri Smith, Head of Policy and Parliamentary Affairs, Terence Higgins Trust Martin Tod, Chief Executive, Men’s Health Forum Martin Tod, Chief Executive, Men’s Health Forum Professor Martin Widschwendter, Professor in Women's Cancer, University College London Professor Martin Widschwendter, Professor in Women's Cancer, University College London Support for the HPV Coalition is provided by BD UK Ltd, Hologic UK Ltd, MSD UK Ltd, and Roche Diagnostics UK Ltd , who fund HPV Coalition meetings, activities, and the HPV Coalition secretariat, delivered by Incisive Health.

Awarded October 2012

Corporate supporters have no influence or input in the selection or content of HPV Coalition projects or communications. Members of the HPV Coalition receive no payment for their involvement in the group, except to cover appropriate travel costs for attending meetings. For further information on our please find the HPV Coalition’s Terms of Reference below. Once again, Outvertising gathered leaders from media, creative, brands and journalism for a half-day of insight and honesty, exploring what LGBTQIA+ advocacy looks like in a year when political headwinds are fierce, cultural tensions are high and inclusive work has never mattered more.

Programme Benefits

The Coalition will stand at the forefront of UK policymaking and will bring together a membership of patient organisations, professional groups, clinicians, and vigora spray expert individuals to build and demonstrate broad stakeholder consensus around the significant – and as yet unharnessed – opportunity to pursue eliminationin the UK. The membership will advocate for commitment and action from all UK governments to pursue elimination of the whole range of HPV-related cancers, in both men and women.

Product	Dosage	Quantity + Bonus	Price
Cialis Generic	10mg	90 + 6 Pills	146.17€ 139.21€	Buy
Cialis Generic	5mg	30 + 4 Pills	53.56€ 51.01€	Buy
Cialis Generic	40mg	60 + 6 Pills	130.98€ 124.74€	Buy
Cialis Generic	5mg	120 + 6 Pills	132.92€ 126.59€	Buy
Levitra Professional	20mg	60 + 2 Pills	223.11€ 212.49€	Buy
Levitra Original	20mg	4 Pills	45.87€ 43.69€	Buy
Viagra Generic	50mg	10 Pills	26.87€ 25.59€	Buy
Levitra Generic	60mg	10 Pills	47.42€ 45.16€	Buy
Levitra Generic	10mg	20 Pills	46.54€ 44.32€	Buy
Levitra Generic	60mg	180 + 10 Pills	501.43€ 477.55€	Buy
Cialis Original	20mg	120 + 8 Pills	497.29€ 473.61€	Buy
Viagra Generic	50mg	60 + 4 Pills	83.93€ 79.93€	Buy
Cialis Generic	2.5mg	90 + 6 Pills	112.43€ 107.08€	Buy

As a first step on this journey, the HPV Coalition will develop a UK elimination roadmap, clearly setting out the steps required to achieve elimination of HPV-related cancers, including the areas where further research is required. On October 24th 2022, the Coalition was officially launched in the Palace of Westminster in an event hosted by long standing HPV advocate, Jess Phillips MP.

• The website emphasizes the need for increased disability representation in media.
• It highlights the importance of accessible voting procedures.
• Campaigns include improving workplace accommodations.
• The platform discusses the impact of COVID-19 on disabled populations.
• It advocates for mental health support tailored for disabled individuals.
• The site strives to counter stereotypes and promote positive images.
• It encourages inclusive design in public and private spaces.
• The platform supports education reforms for greater awareness.
• It campaigns against disability hate crimes.
• The website provides statistics to underline the scope of issues faced.

The HPV Coalition is proud to publish the next step in that journey, our Roadmap towards making the elimination of all HPV-related cancers a reality across the UK, which you can read below. The Roadmap serves as our call to Governments across the four nations of the UK to take action, while providing the blueprint of how elimination can be delivered.

Indicator	Result	Year	Notes
Policy Changes	3 laws amended	2023	Following advocacy efforts
Media Coverage	25 articles	2023	News outlets and blogs
Volunteer Sign-ups	1,200	2023	New volunteers for campaigns
Events Organized	12	2023	Community rallies and online webinars

Our goal is simple Make the elimination of all HPV-related cancers a reality across the UK. We have many of the tools available to us now to make this a reality, and we must ensure it is grasped without delay.

Work Based Learning Programme Specification and Guidance

“Has Age Replaced Class in British Elections? A Hierarchical Age-Period-Cohort Analysis.” Electoral Studies 86. doi:10.1016/j.electstud.2023.102695. Why Did Labour Party Membership Soar after the 2015 General Election?” The British Journal of Politics and International Relations 21(1): 80–98. “What Kind of Party Is the UK Independence Party?

Kevin Malone

The Future of the Extreme Right in Britain or Just Another Tory Party?” Political Studies 66(3): 577–600. “White, Male, and Angry: A Reputation-Based Rationale.” SSRN Electronic Journal. “How Do Economic Crises Affect Electoral Choices? Analyzing Voting Behavior in the British General Election of 2010.” In Economic Crises and Policy Regimes: The Dynamics of Policy Innovation and Paradigmatic Change, ed. Using Home Movers to Identify Local Campaign Effects.

Awarded April 2013

“Partisanship, Attribution and Approval in a Public Health Shock.” Electoral Studies 84. doi:10.1016/j.electstud.2023.102643. “Explaining Reactions to Inflation: Early-Life Experiences and Mass Preferences for Price Increases.” (4686442). “UKIP Support in Local Elections: Which Factors Play a Role in Determining Electoral Fortunes?” British Politics 18(4): 623–46. “The Electoral Effects of the Descriptive Representation of Ethnic Minority Groups in Australia and the UK.” Party Politics 22(6): 691–704. To achieve this, we must ensure foundations of HPV prevention are strengthened across the UK.

OpenTable ‘The BillBoard’ (2045)

Our Roadmap is therefore made up of a number of building blocks – with associated actions – that plot our course to elimination: Improving education on HPV to tackle stigma and drive access to prevention Making sure everyone has equitable access to screening and early diagnosis Restoring and boosting immunisation uptake, including catch-up programmes Enhancing the data, digital and workforce infrastructure It is critical that UK governments set out a concrete strategy for the elimination of all HPV-related cancers, widening the scope of our ambition beyond cervical cancer elimination.

Economy Futures Fund - Welsh Industrial Development Advisory Board – Meeting of 2 March 2021

Sara Cropley

Kevin O'Dell

Along with our fellow members of the HPV Coalition, we stand ready to support the implementation of recommendations and take meaningful steps to prevent HPV-related cancers from affecting the lives of so many women and men. We recognise that concerted and collaborative action is essential to success, and therefore the HPV Coalition is committed to working in close and positive partnership with parliamentarians and policymakers in support of elimination ambitions, ensuring that the UK’s current opportunity to lead the world in HPV elimination is not missed.

Cultural Recovery Grant

For further information on HPV Coalition activity please contact the secretariat – provided by Incisive Health – at HPVCoalition@incisivehealth.com. Co-Chair: Samantha Dixon, Chief Executive, Jo’s Cervical Cancer Trust Co-Chair: Samantha Dixon, Chief Executive, Jo’s Cervical Cancer Trust Co-Chair: David Winterflood, Chief Executive, NOMAN Campaign Co-Chair: David Winterflood, Chief Executive, NOMAN Campaign Peter Baker, Director, Global Action on Men’s Health and formerly Campaign Director HPV Action Peter Baker, Director, Global Action on Men’s Health and formerly Campaign Director HPV Action Dr Jake Bayley, Consultant in sexual health and Chair, HPV Special Interest Group, British Association for Sexual Health and HIV Dr Jake Bayley, Consultant in sexual health and Chair, HPV Special Interest Group, British Association for Sexual Health and HIV Dr Nigel Carter, Chief Executive, Oral Health Foundation Dr Nigel Carter, Chief Executive, Oral Health Foundation Professor Emma Crosbie, Professor of Gynaecological Oncology Professor Emma Crosbie, Professor of Gynaecological Oncology Dr Kate Cuschieri, Director of Human Papillomavirus Research Group & Scottish HPV Reference Laboratory, University of Edinburgh Dr Kate Cuschieri, Director of Human Papillomavirus Research Group & Scottish HPV Reference Laboratory, University of Edinburgh Dr Anne Connolly, Chair, Primary Care Women’s Health Forum Dr Anne Connolly, Chair, Primary Care Women’s Health Forum Robert Cornes, Male Cancer Information Nurse Specialist, ORCHID Penile Cancer Robert Cornes, Male Cancer Information Nurse Specialist, ORCHID Penile Cancer Dr Jennifer Davies-Oliveira, Clinical Research Fellow Gynaecology-Oncology, University of Manchester Dr Jennifer Davies-Oliveira, Clinical Research Fellow Gynaecology-Oncology, University of Manchester Helen Donovan, Immunisation and Vaccination Specialist Nurse Helen Donovan, Immunisation and Vaccination Specialist Nurse Anita Harris, Director of Clinical Operations, Brook Anita Harris, Director of Clinical Operations, Brook Melvyn Hill, Chief Executive, UK Cervical Cancer Melvyn Hill, Chief Executive, UK Cervical Cancer Catrin Hughes, Faculty of Sexual and Reproductive Healthcare Catrin Hughes, Faculty of Sexual and Reproductive Healthcare Vas James, Head of Programmes, The Eve Appeal Vas James, Head of Programmes, The Eve Appeal Lorna Kelly, Faculty of Sexual and Reproductive Healthcare Lorna Kelly, Faculty of Sexual and Reproductive Healthcare Tamara Kahn, Chief Executive, Oracle Cancer Trust Tamara Kahn, Chief Executive, Oracle Cancer Trust Athena Lamnisos, Chief Executive, The Eve Appeal Athena Lamnisos, Chief Executive, The Eve Appeal Hilary Maxwell, CEO and Chair, GO Girls Hilary Maxwell, CEO and Chair, GO Girls Dr Fernanda Perez, Policy and Public Affairs Executive, Royal Society of Public Health Dr Fernanda Perez, Policy and Public Affairs Executive, Royal Society of Public Health Dr Gillian Prue, Reader in Chronic Illness, Queen’s University Belfast Dr Gillian Prue, Reader in Chronic Illness, Queen’s University Belfast Heather Randle, Professional Lead for Education and Primary Care, Royal College of Nursing Heather Randle, Professional Lead for Education and Primary Care, Royal College of Nursing Professor Peter Sasieni, Professor of Cancer Prevention, King’s College of London Professor Peter Sasieni, Professor of Cancer Prevention, King’s College of London Dr Sue Sherman, Reader in Psychology, Keele University Dr Sue Sherman, Reader in Psychology, Keele University Ceri Smith, Head of Policy and Parliamentary Affairs, Terence Higgins Trust Ceri Smith, Head of Policy and Parliamentary Affairs, Terence Higgins Trust Martin Tod, Chief Executive, Men’s Health Forum Martin Tod, Chief Executive, Men’s Health Forum Professor Martin Widschwendter, Professor in Women's Cancer, University College London Professor Martin Widschwendter, Professor in Women's Cancer, University College London Support for the HPV Coalition is provided by BD UK Ltd, Hologic UK Ltd, MSD UK Ltd, and Roche Diagnostics UK Ltd , who fund HPV Coalition meetings, activities, and the HPV Coalition secretariat, delivered by Incisive Health.

Content Type	Quantity	Last Update	Purpose
Blog Posts	45	Weekly	Educate and engage visitors
Campaign Videos	15	Monthly	Visual storytelling
Newsletters	20	Bi-weekly	Updates and calls to action
Infographics	8	Quarterly	Simplify data & advocacy messages

Corporate supporters have no influence or input in the selection or content of HPV Coalition projects or communications.

Vanguard Membership Fee 2021 to 2022

Members of the HPV Coalition receive no payment for their involvement in the group, except to cover appropriate travel costs for attending meetings. For further information on our please find the HPV Coalition’s Terms of Reference below. Once again, Outvertising gathered leaders from media, creative, brands and journalism for a half-day of insight and honesty, exploring what LGBTQIA+ advocacy looks like in a year when political headwinds are fierce, cultural tensions are high and inclusive work has never mattered more.

Funding for a Business Productivity Enhancement Project

“Turnout Turnaround: Ethnic Minority Victories Mobilize White Voters.” American Political Science Review. The NOMAN is an Island: Race to End HPV Campaign is joining forces with Jo’s Cervical Cancer Trust to launch and co-chair a new HPV Coalition. The HPV Coalition, established in 2022, is an expert advisory group of leading patient groups, professional groups, clinicians, and expert individuals who have come together to inform and advance the UK’s journey towards elimination of HPV-related cancers – cancers which account for 5% of all cancers globally, and which we now, for the first time in history, have the opportunity to eliminate as a public health threat. Despite the scale of the opportunity, the UK has yet to take the step of other countries, such as Australia and Canada, in developing an action plan for cervical cancer elimination. The UK also lags behind the European Union which, through the Beating Cancer Plan, has gone one step further, in committing to eliminate all HPV cancers.

Nicola Gibson

The HPV Coalition is therefore eager to see the UK put in place a concrete plan for elimination as a matter of priority, targeted at the whole range of HPV-related cancers and supporting access to preventative interventions for all parts of the population. The Coalition will stand at the forefront of UK policymaking and will bring together a membership of patient organisations, professional groups, clinicians, and vigora spray expert individuals to build and demonstrate broad stakeholder consensus around the significant – and as yet unharnessed – opportunity to pursue eliminationin the UK. The membership will advocate for commitment and action from all UK governments to pursue elimination of the whole range of HPV-related cancers, in both men and women. As a first step on this journey, the HPV Coalition will develop a UK elimination roadmap, clearly setting out the steps required to achieve elimination of HPV-related cancers, including the areas where further research is required. On October 24th 2022, the Coalition was officially launched in the Palace of Westminster in an event hosted by long standing HPV advocate, Jess Phillips MP.

Programme Overview

The HPV Coalition is proud to publish the next step in that journey, our Roadmap towards making the elimination of all HPV-related cancers a reality across the UK, which you can read below. The Roadmap serves as our call to Governments across the four nations of the UK to take action, while providing the blueprint of how elimination can be delivered. Our goal is simple Make the elimination of all HPV-related cancers a reality across the UK. We have many of the tools available to us now to make this a reality, and we must ensure it is grasped without delay. To achieve this, we must ensure foundations of HPV prevention are strengthened across the UK.